The Bone Morphogenetic Protein (BMP) market is a subset of the biomaterials industry. BMPs are proteins that can induce bone and cartilage formation, and are used in a variety of medical applications, such as spinal fusion, fracture repair, and dental implants. BMPs are typically derived from recombinant DNA technology, and are used in combination with other biomaterials, such as ceramics, polymers, and metals. The BMP market is expected to grow in the coming years, driven by the increasing demand for bone and cartilage regeneration, as well as the development of new technologies and products. Additionally, the increasing prevalence of chronic diseases, such as osteoporosis, is expected to drive the demand for BMPs. Some of the major companies in the BMP market include Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew. These companies are involved in the development, manufacturing, and marketing of BMPs and related products. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.